Lantern Pharma Archives - Vista Partners LLC

CXApp’s Agentic AI Transformation – $CXAI $AMZN $GOOG

by John F. Heerdink, Jr. April 4, 2025 121Views 0Likes

CXApp Inc.(NASDAQ: CXAI, $1.42, +76% on Friday), headquartered in Palo Alto, California, is a pioneering force in workplace experience technology. The company provides an innovative enterprise platform that leverages artificial intelligence (AI) and customer experience (CX) principles to reimagine employee interactions…

Jazz Pharmaceuticals’ Chimerix Acquisition Marks Significant Milestone In Precision Neuro-Oncology – ( $JAZZ $CMRX $LTRN )

by John F. Heerdink, Jr. March 6, 2025 132Views 0Likes

Jazz Pharmaceuticals' (NASDAQ: JAZZ) $935 million acquisition of Chimerix (NASDAQ: CMRX) marks a significant milestone in precision neuro-oncology, highlighting the growing potential of targeted therapies for brain cancers and signaling a shift towards biomarker-driven approaches in treating central nervous system tumors. The…

Lantern Pharma

CXApp’s Agentic AI Transformation – $CXAI $AMZN $GOOG

Jazz Pharmaceuticals’ Chimerix Acquisition Marks Significant Milestone In Precision Neuro-Oncology – ( $JAZZ $CMRX $LTRN )

Your Guide To Staying Informed In The Markets